⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
Inflammaging
Current understanding
Chronic low-grade inflammation as both marker and driver of aging.
Evidence log
- 2026-11-14 — Immunosenescence and vaccine adjuvants in older adults: from immune decline to signal reconstitution strategies.: [expert-opinion] Review, no new primary data: its framework of targeted signal amplification, reconstitution, and bypass highlights why restoring vaccine-responsive immune signaling is a distinct therapeutic aim from reducing chronic inflammatory tone, without newly demonstrating that adjuvants reduce human inflammaging. [expert-opinion] (novelty: 3)
- 2026-11-13 — Cellular senescence and the hallmarks of ageing: Evaluating evidence for a causal mechanistic role.: [expert-opinion] Review, no new primary data: situates senescence-associated inflammatory signaling within a bidirectional hallmark network, framing inflammation as both an input to and output of senescence without establishing the relative contribution of this feedback loop to human aging or clinical benefit from interrupting it. [expert-opinion] (novelty: 3)
- 2026-11-14 — Beyond Hematopoiesis: How Immune Are Hematopoietic Stem Cells?: [expert-opinion] Review, no new primary data: synthesizes direct inflammatory sensing by hematopoietic stem cells and lasting epigenetic reprogramming into a proposed feedback loop in which chronic activation promotes replicative stress, myeloid bias, and selection of CHIP-associated clones that can sustain inflammation, without establishing the complete causal sequence or therapeutic reversibility in humans. [expert-opinion] (novelty: 3)
- 2026-11-15 — Inflammatory biomarkers in late-life depression: a systematic review and meta-analysis of interleukin-1β, interleukin-6, tumor necrosis factor-α, and C-reactive protein.: [human-observational] A systematic review and meta-analysis of 18 observational studies found significantly higher peripheral IL-1β, IL-6, TNF-α, and CRP in older adults with late-life depression than healthy controls, linking canonical inflammaging markers to late-life mood disorder without establishing causal direction, brain inflammation, or benefit from anti-inflammatory treatment. [human-observational] (novelty: 3)
- 2026-11-12 — Chronobiology of Aging: Interactions Between Circadian Rhythms, Oxidative Stress, and Inflammation.: [expert-opinion] Review, no new primary data: positions circadian disruption as a proposed upstream contributor to coupled oxidative stress and chronic inflammation across aging hallmarks, without establishing its causal primacy or demonstrating that multimodal chronotherapy extends human healthspan. [expert-opinion] (novelty: 3)
- 2026-11-01 — The AIM2 inflammasome drives age-dependent cardiac dysfunction following ischemia-reperfusion in mice.: Mouse ischemia-reperfusion study [animal-model] identifies age-dependent AIM2 inflammasome induction as a driver of cardiac inflammatory priming, pyroptosis, and worsened post-injury dysfunction, with age-associated AIM2 upregulation in human cardiac data [human-observational] but no demonstrated human causal role or therapeutic benefit. [animal-model] (novelty: 3)
- 2026-11-10 — The neuro-inflammaging triangle: a self-amplifying circuit of protein pathology, senescence-associated secretory phenotype and innate immunity in neurodegenerative disease.: [expert-opinion] Review, no new primary data: proposes a ‘neuro-inflammaging triangle’ in which protein aggregation, senescence-associated secretory phenotype (SASP), and innate danger sensing sustain neuroinflammation across neurodegenerative diseases, extending existing feedback-loop frameworks without establishing the complete circuit or multi-target treatment benefit in humans. [expert-opinion] (novelty: 3)
- 2026-11-01 — Inflammaging as a Dynamic Process in Ageing: Context, Regulation and Functional Consequences.: [expert-opinion] Review, no new primary data: proposes four inflammaging states—S0 resolved, S1 compensatory, S2 maladaptive but conditionally reversible, and S3 self-sustaining—extending existing failed-resolution frameworks with a hypothesized S2 intervention window whose identification and therapeutic reversibility remain unvalidated in humans. [expert-opinion] (novelty: 3)
- 2026-11-12 — Granzyme K is a driver of age-related tissue remodeling and functional decline independently of age-associated immune dysfunction.: [animal-model] A mouse knockout study identifies granzyme K as a tissue-specific contributor to age-related kidney and liver fibrosis and dysfunction despite persistent measured immune-aging hallmarks, refining the distinction between tissue-damaging effectors and immune senescence without establishing reduced systemic inflammaging or human therapeutic benefit. [animal-model] (novelty: 4)
- 2026-11-09 — TMAO regulates renal tubular epithelial cell senescence through circVmn2r1.: [animal-model] A mouse and renal tubular epithelial cell study places circVmn2r1-mediated NLRP3 activation downstream of TMAO in renal senescence and kidney aging, extending tissue-specific inflammasome mechanisms without establishing systemic inflammaging effects or human treatment benefit. [animal-model] (novelty: 3)
- 2026-10-21 — Relationship Between Social Isolation, Loneliness, and Systemic Inflammation: A Scoping Review of Biological Signatures and Clinical Outcomes.: [human-observational] A scoping review of 73 human studies links social isolation and loneliness to elevated CRP, fibrinogen and IL-6, proteomic alterations and accelerated epigenetic aging, with reported partial statistical mediation of sarcopenia, cardiovascular disease and mortality associations, without establishing causal mediation or showing that reducing social disconnection reverses these signatures or improves outcomes. [human-observational] (novelty: 3)
- 2026-10-07 — Gut microbiota alterations associated with dietary inflammation and sarcopenia in humans and aged mice: insights from integrated metabolomic analysis.: [human-observational] In 1,048 older adults, higher dietary inflammatory index was associated with sarcopenia, linking dietary inflammatory potential to muscle aging without establishing chronic systemic inflammation as the mediator or demonstrating dietary treatment benefit. [human-observational] (novelty: 3)
- 2026-10-19 — Resistance Training Improves Respiratory Muscle Strength and Immune Response in Older Adults: A Randomized Clinical Trial.: [human-rct] A 12-week randomized clinical trial in older adults reported improved systemic inflammatory balance alongside respiratory muscle strength and physical performance after supervised resistance training, without establishing that inflammatory changes mediated functional gains or slowed aging. [human-rct] (novelty: 3)
- 2026-08-07 — MDM2 deletion and its associated p53 activation in subcutaneous white adipose tissue induce hepatic fibrosis via galectin-3 in a mouse model.: [animal-model] Mouse MDM2-deletion study identifies senescent subcutaneous adipocytes as a source of galectin-3-mediated hepatic fibrosis, extending senescence-linked interorgan signaling beyond visceral fat without establishing generalized age-related low-grade inflammation or human therapeutic benefit. [animal-model] (novelty: 3)
- 2026-10-12 — Biological Aging, Adiposity, and Inflammation in Degenerative Spine Disease: Mendelian Randomization and Longitudinal United Kingdom Biobank Analyses.: [human-observational] Longitudinal UK Biobank analyses with Mendelian randomization support causal contributions of adiposity and systemic inflammation indexed by CRP to degenerative spine disease, conditional on genetic-instrument assumptions, without establishing that lowering CRP or adiposity therapeutically prevents spinal degeneration. [human-observational] (novelty: 3)
- 2026-10-12 — When Does Polyendocrine Metabolic Ovarian Syndrome (PMOS) Change Definition? A Lifespan Perspective on Menopause and Metabolic Health.: [expert-opinion] Review, no new primary data: frames persistent postmenopausal metabolic dysfunction in polyendocrine metabolic ovarian syndrome (PMOS) as a cardiometabolic aging phenotype, providing indirect context for metabolic–inflammatory aging models but no inflammatory measurements or evidence establishing inflammaging as the mediator in the supplied finding. [expert-opinion] (novelty: 3)
- 2026-10-23 — Leptin Neutralization Attenuates Inflammaging in Endothelial and Immune Cell Models.: [mechanism-plausible] Endothelial and immune cell-culture experiments report that leptin receptor blockade reduces inflammatory markers and SASP output, implicating leptin–mTOR signaling as a candidate inflammaging input without demonstrating organism-level healthspan effects or human treatment benefit. [mechanism-plausible] (novelty: 3)
- 2026-10-26 — Cardiovascular resilience in centenarians.: [expert-opinion] Review, no new primary data: counterbalancing anti-inflammatory signaling is proposed to help centenarians tolerate cardiovascular aging, extending the regulated-inflammaging framework without establishing causal protection or showing that anti-inflammatory treatment reproduces this phenotype in humans. [expert-opinion] (novelty: 3)
- 2026-10-21 — Associations of longitudinal patterns of central obesity and chronic low-grade inflammation with incident frailty in middle-aged and older adults.: [human-observational] Prospective longitudinal trajectory study of over 7,000 middle-aged and older adults found persistent central obesity and elevated CRP independently and synergistically associated with incident frailty, with central adiposity temporally preceding systemic inflammation; observational timing does not establish causation or show that reducing adiposity or CRP prevents frailty. [human-observational] (novelty: 3)
- 2026-11-04 — Longitudinal associations between the hallmarks of aging and body composition: a narrative review.: [human-observational] A narrative review of 50 longitudinal human studies identified chronic inflammation alongside deregulated nutrient sensing as the principal hallmarks associated with body-composition remodeling, while highlighting gaps for cellular senescence, epigenetic alterations, and autophagy rather than demonstrating their absence as biological contributors. [human-observational] (novelty: 3)
- 2026-11-01 — Constitutive Activation of Skeletal Muscle mTORC1 Drives Pro-Inflammatory Gene Expression in Skeletal Muscle of Aged Mice.: [animal-model] A muscle-specific Depdc5-knockout study in 27-month-old mice identifies constitutive mTORC1 activation as sufficient to exacerbate local inflammatory gene expression and TNF-α levels, while dietary rapamycin did not dampen these induced markers despite partial rescue of the phenotype; systemic inflammatory consequences and human relevance remain unestablished. [animal-model] (novelty: 3)
- 2026-10-07 — Chronic inflammation and multiple dimensions of aging among women in the Philippines.: 7-year longitudinal study of Filipino women (Cebu Longitudinal Health and Nutrition Survey) found baseline plasma CRP and a DNA-methylation CRP surrogate both predicted declines in physical and cognitive function and higher incidence of diabetes and hypertension — extends inflammaging’s predictive validity to a lower-middle-income, lower-obesity, higher-infectious-burden setting outside the usual high-income cohorts. [human-observational] (novelty: 3)
- 2026-10-10 — Bone marrow adipose tissue in cardiometabolic disease: marrow niche remodeling, inflammatory hematopoiesis, and vascular pathology.: 2026 BMAT-in-cardiometabolic-disease review nominates expanded bone marrow adipose tissue as a marrow-niche source of inflammatory hematopoiesis contributing to systemic inflammaging tone — narrative synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-10-09 — Decoding the immune regulation of ovarian aging: mechanisms and therapeutic strategies.: 2026 review nominates ovarian-local inflammaging (resident immune-cell remodeling plus systemic SASP spillover) as a causal driver of physiological ovarian aging and POI, extending the organ-specific inflammaging roster to the ovary and framing immunomodulation as a candidate reproductive-lifespan lever — synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-10-08 — Biomarker-Guided, Stage-Specific Senotherapy for Metabolic Dysfunction-Associated Steatotic Liver Disease.: 2026 MASLD Perspective positions long-term senomorphic dampening of hepatic SASP as the maintenance phase of a biomarker-guided senotherapy sequence, treating liver-tissue inflammaging as a stage-stratified therapeutic axis rather than a continuous target — conceptual framing only, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-10-07 — Plasma proteomic signatures of biological aging and metabolic dysfunction-associated steatotic liver disease risk: a prospective cohort study.: 2026 UK Biobank prospective proteomic mediation analysis: a five-protein core signature (AXL, CCL19, CPM, REN, TNFRSF11B) — overlapping prior inflammaging protein indices (TNFRSF11B, CXCL9/IL-6 family) — partially mediates the link between four biological-age metrics and incident MASLD via multi-organ immune-inflammatory pathways, extending inflammaging protein signatures from mortality/multimorbidity readouts to a specific incident metabolic-liver disease endpoint. [human-observational] (novelty: 3)
- 2026-10-10 — THE AGING PURINOME: A PURINERGIC FRAMEWORK LINKING THE HALLMARKS OF AGING TO INFLAMMAGING.: 2026 Aging Purinome review nominates age-remodeled extracellular purinergic signaling (ATP/adenosine via P2X/P2Y/adenosine receptors and ectonucleotidases) plus NAD±metabolism shifts as an integrative upstream substrate feeding chronic low-grade inflammation, extending the inflammaging driver menu with a purinergic axis — conceptual synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-09-28 — Uncertainty redefines biological age: UK Biobank observational study (>450k) introduces Biological Age Uncertainty (BAU) — the width of predicted-age distributions across aging models — as an independent predictor of mortality and multimorbidity, framing loss of coherence across inflammation-containing aging signals (not just elevated inflammatory tone) as a distinct risk axis. [human-observational] (novelty: 4)
- 2026-09-29 — α‐Synuclein Promotes Atherosclerosis by Impairing Macrophage Autophagic Flux: Preclinical study: α-synuclein-driven impairment of macrophage autophagic flux promoted atherosclerotic inflammation, consistent with (but not directly measuring as a cytokine panel) the autophagy-failure→plaque-macrophage inflammatory tone arm of vascular inflammaging. [animal-model] (novelty: 3)
- 2026-09-29 — Ghrelin Alleviates Aging‐Related Cognitive Impairment by Regulating Autophagy‐Related Signaling via the SHBG/JNK1/Beclin1 Axis in Microglia: Preclinical mouse + cell study with human association data: ghrelin dampens microglial inflammation in aging-related cognitive impairment via SHBG/JNK1/Beclin1-driven autophagy, nominating a declining endocrine signal as an upstream anti-neuroinflammaging lever in brain-resident myeloid cells. [animal-model] (novelty: 3)
- 2026-09-30 — Single‐Cell Mapping Identifies Aging‐Associated Neutrophil Remodeling Across Multiple Organs: Multi-organ single-cell neutrophil atlas (preclinical) documents age-associated remodeling of neutrophil subsets across tissues, extending the roster of granulocyte contributors to tissue-local sterile inflammatory tone — descriptive only, no cytokine or outcome data. [animal-model] (novelty: 3)
- 2026-04-03 — A 3-N nose-to-brain urolithin a nanomotor targeting microglial mitophagy in neuroinflammation.: LPS-induced neuroinflammation mouse model: intranasal urolithin A nanomotor dampened microglial neuroinflammation and oxidative stress via restored mitophagy, offering a CNS-targeted preclinical instance of the mitophagy-failure→microglial inflammatory tone arm of neuroinflammaging. [animal-model] (novelty: 3)
- 2026-07-17 — Is Urolithin A(UA) a pharmacologically credible neuro-nutraceutical? A critical review of mechanisms, brain exposure, and evidence gaps in Alzheimer’s and Parkinson’s disease.: 2026 Urolithin A neuro-nutraceutical review nominates UA as a candidate dampener of microglial/neuroinflammatory tone in AD/PD models while cautioning that human effects to date are confined to safety and skeletal-muscle readouts rather than CNS inflammatory endpoints — synthesis only, no cytokine data. [expert-opinion] (novelty: 3)
- 2026-07-11 — Chronic subdural hematoma as failed resolution at the aged dura-subdural interface: Immune-vascular mechanisms, biomarker interpretation, and therapeutic translation.: 2026 CSDH review casts chronic subdural hematoma recurrence as a tissue-local inflammaging/failed-resolution lesion in which aged dural immune-vascular signaling sustains fibrinolysis imbalance and prevents hematoma clearance — synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-09-03 — IL-21R blockade reduces inflammation and atherosclerosis in LDL receptor deficient mice.: IL-21R monoclonal antibody blockade in young and aged Ldlr-/- mice reduced atherosclerotic plaque area and residual plaque inflammation, lowered pro-inflammatory monocytes, and expanded atheroprotective Tregs — adds a specific cytokine-receptor axis to the druggable anti-inflammaging roster at the arterial wall, with human plaque scRNAseq confirming IL-21R expression on Tregs but no human efficacy data. [animal-model] (novelty: 3)
- 2026-10-01 — Associations Between Gut Microbiota and Immune Profiles in Community-Dwelling Older Adults and the Regulatory Role of Polygonatum odoratum.: 2026 90-day RCT (n=140, older adults) of Polygonatum odoratum reported fewer respiratory infections alongside microbiota and T-cell shifts, consistent with (but not directly measuring) dampening of the dysbiosis→immunosenescence→chronic inflammatory tone arm of inflammaging in community-dwelling older adults. [human-rct] (novelty: 3)
- 2026-10-01 — Ghrelin Alleviates Aging-Related Cognitive Impairment by Regulating Autophagy-Related Signaling via the SHBG/JNK1/Beclin1 Axis in Microglia.: Mouse + cell preclinical study with human association data: ghrelin dampens microglial inflammation in aging-related cognitive impairment via SHBG/JNK1/Beclin1-driven autophagy, nominating a declining endocrine signal as an upstream anti-neuroinflammaging lever in brain-resident myeloid cells. [animal-model] (novelty: 3)
- 2026-10-06 — Sex-stratified immune patterns across the canine lifespan and short-term responses to geroprotective interventions.: Laboratory-Beagle cross-sectional study plus 90-day exploratory arms: sex-stratified age-related cytokine trajectories in dogs, with short-term rapamycin showing the broadest exploratory cytokine shift among rapamycin, canagliflozin, and dietary restriction — small-n preclinical signal that mTOR inhibition reaches the dog systemic inflammatory tone on a short timeframe. [animal-model] (novelty: 3)
- 2026-10-01 — Endothelial TLR4 at the Crossroads of Vascular Senescence and Targeted Senotherapeutics.: 2026 review nominates chronic endothelial TLR4 engagement by sterile DAMPs as a vascular-wall source of inflammaging tone, with precision endothelium-targeted TLR4 inhibition proposed as a tissue-local dampener distinct from systemic anti-inflammatory blockade — conceptual synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-08-22 — Ensemble DNA methylation clock demonstrates Immune-metabolic aging signatures associated with mortality.: 2026 Framingham ensemble DNAm survival clock (190 CpGs) that matches GrimAge on mortality prediction highlights immune-metabolic CpG signatures, consistent with inflammaging being a dominant readout embedded in mortality-trained methylation clocks — observational, methodological signal rather than new cytokine data. [human-observational] (novelty: 3)
- 2026-10-05 — Electroacupuncture Targeting the NLRP3 Inflammasome in Senescence‑associated Cognitive Impairment: Mechanistic Synthesis and Meta‑analysis of Clinical Randomized Controlled Trials.: 2026 meta-analysis of 9 RCTs (n≈599 completers) in MCI/early AD: electroacupuncture associated with short-term MoCA/MMSE gains and lower circulating IL-6, framed mechanistically as multi-axis dampening of NLRP3-driven neuroinflammation — human-trial-level signal that a non-pharmacologic modality moves one canonical inflammaging cytokine in a cognitive-impairment population, no durable disease-modification endpoint. [human-rct] (novelty: 3)
- 2025-11-22 — Nicotinamide riboside supplementation restores microglial health and improves cognition in aged male mice.: Aged male mouse study: 8-week nicotinamide riboside (400 mg/kg) shifted aged microglia away from ADEM/DAM-like inflammatory states toward a younger homeostatic transcriptomic phenotype alongside cognitive improvement, adding an NAD-precursor-driven dampening of brain-local inflammaging in naturally aged mice. [animal-model] (novelty: 3)
- 2026-10-06 — Multimodal Technology-Driven aging Research: Decoding the Mitochondria‒Pyroptosis axis in muscle atrophy and cognitive decline.: 2026 multimodal-framework review nominates mtDNA-triggered NLRP3-driven pyroptosis as the inflammatory effector arm bridging mitochondrial dysfunction to tissue-local inflammaging hotspots in aging muscle and brain — synthesis only, no cytokine or outcome data. [expert-opinion] (novelty: 3)
- 2026-10-05 — Decline of chaperone-mediated autophagy in aging impairs macrophage clearance of senescent cells.: Preclinical cell + aged-mouse study: CMA decline both rewires SASP output and cripples macrophage clearance of senescent cells, feeding tissue-local inflammatory tone; CMA activators lowered senescent burden in aged mice and in a pulmonary fibrosis model, nominating a proteostasis lever that simultaneously dampens the SASP source and restores the clearance arm of inflammaging. [animal-model] (novelty: 4)
- 2026-10-05 — Therapeutic reversal of cellular senescence: A systematic review of senolytics, senomorphics and anti-ageing therapies in human clinical trials.: 2026 systematic review of human senolytic/senomorphic trials notes that reported effects to date cluster on SASP/inflammatory-marker shifts rather than durable clinical outcomes, consistent with inflammaging-arm modulation outpacing senescent-cell-burden-outcome evidence in humans — synthesis only, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-10-05 — Senotherapeutic potential against xeroderma pigmentosum.: XP patient-derived melanocyte drug screen: JAK inhibitors and curcuminoid senomorphics dampened UV-induced SASP output alongside BCL-2-like/HSP90 senolytic clearance, adding a monogenic DNA-repair-deficiency photoaging context to the roster of settings where JAK-STAT-targeted senomorphics attenuate tissue-local inflammatory tone — cell-culture only. [mechanism-plausible] (novelty: 3)
- 2026-03-11 — Communication breakdown: senescent cells in interorgan communication of aging.: 2026 opinion review positions SASP-driven inflammaging as the downstream effector by which senescent cells coordinate interorgan aging signals, consolidating the senescence→immune-amplified low-grade inflammation→systemic aging arc at the conceptual level; synthesis only, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-05-20 — Single-cell multiomics gene regulatory landscape reveals impaired spermatogonial stem cells and macrophage-driven inflammaging during testicular aging.: 2026 single-cell multiomics atlas of aged mouse testes nominates expanded CD206+ tissue-resident macrophages signaling via CXCL13 as a tissue-local inflammaging driver of male reproductive decline, extending the organ-specific inflammaging roster to the testis with a specific macrophage subset and chemokine ligand. [animal-model] (novelty: 3)
- 2026-10-01 — Inflammaging reshapes the immune ecosystem in IgG4-related dacryoadenitis and sialadenitis.: 2026 human lesional-transcriptome study of IgG4-related dacryoadenitis and sialadenitis ties age to coordinated upregulation of inflammaging, SASP/senescence, cytotoxic/exhaustion, and stromal/fibrotic programs with reduced germinal-centre activity, extending inflammaging to a specific autoimmune fibro-inflammatory tissue context — observational human lesion data, no cytokine trial. [human-observational] (novelty: 3)
- 2026-09-28 — Functional Shift of NLRP3 Inflammasome Activity in Aged Macrophages.: Aged-macrophage preclinical study: NLRP3 inflammasome activity shifts away from proinflammatory cytokine secretion toward apoptosis–senescence regulation with age, suggesting canonical NLRP3-driven cytokine framings of inflammaging may not describe late-life macrophages — cell-level only. [mechanism-plausible] (novelty: 3)
- 2026-10-01 — Therapeutic Immune Reprogramming by Rapamycin Attenuates Plaque Inflammation and Lymphoid Immune Responses in Aged Atherosclerotic Mice.: Aged atherosclerotic mouse study: therapeutic rapamycin reduced plaque macrophage inflammation and dampened effector lymphoid responses while expanding Treg-type regulatory populations, offering a tissue-local anti-inflammaging instance of mTOR inhibition inside established atherosclerotic plaque rather than at systemic cytokine level alone. [animal-model] (novelty: 3)
- 2026-04-24 — Mitochondrial Dysfunction and Telomeric Shortening as Long-term Complications After COVID-19.: Post-COVID cohort implicates sustained telomere attrition and mitochondrial protein alterations in pulmonary fibrotic sequelae, consistent with (but not directly measuring) a post-viral inflammaging substrate persisting 1–2 years after hospitalization — observational, no cytokine endpoint reported here. [human-observational] (novelty: 3)
- 2026-06-13 — Cyanidin chloride activates mitophagy to delay aging via PINK1/parkin pathway.: Aging worm + mouse cyanidin chloride study implies dampened age-related inflammatory tone as a downstream consequence of restored PINK1/Parkin mitophagy (reduced damaged-mitochondria DAMP load), consistent with the mitophagy-failure→mtDNA–cGAS/NLRP3→inflammaging arm — inferred, no cytokine panel in the primary report. [animal-model] (novelty: 3)
- 2026-08-18 — The nutrition-sleep-circadian axis in age-related neurodegeneration: Cellular mechanisms, metabolic dysfunction, and neuroprotective interventions.: 2026 integrative review positions chronic neuroinflammation as a core downstream output of a disrupted nutrition–sleep–circadian axis and groups Mediterranean diet, TRE, and circadian light exposure as candidate anti-neuroinflammaging levers for brain aging — conceptual synthesis, no cytokine data. [expert-opinion] (novelty: 3)
- 2026-05-22 — circRNA-engineered macrophages mediate localized MMP9 neutralization to rejuvenate aged bone.: 2026 aged-mouse study: circRNA-LNP-reprogrammed macrophages secreting anti-MMP9 antibodies attenuated SASP output and skeletal inflammatory tone in bone and cartilage, nominating macrophage-derived MMP9 as a tractable local inflammaging substrate in the aged skeletal niche and introducing an in situ antibody-biofactory modality distinct from systemic monoclonal dosing — preclinical only. [animal-model] (novelty: 4)
- 2026-06-16 — Resveratrol suppresses GATA4/Sortilin pathway to attenuate vascular smooth muscle cell senescence-associated secretory phenotype and vascular aging-related atherosclerosis.: 2026 ApoE mouse VSMC study: resveratrol dampened VSMC SASP output via GATA4/Sortilin suppression, extending the GATA4-driven arterial-wall inflammaging axis (previously logged for radiation-induced atrial SASP) into atherogenic vascular smooth muscle — preclinical only. [animal-model] (novelty: 3)
- 2026-06-27 — IL-11 neutralizing antibodies alleviate pulmonary fibrosis in aging mice by inhibiting TGF-β/NOX4/IL-11 signaling pathway.: 2026 aged-mouse study: anti-IL-11 antibody treatment broke a TGF-β/NOX4/IL-11 autocrine loop in aged lung fibroblasts and alleviated pulmonary fibrosis, nominating IL-11 as a tissue-local inflammaging cytokine amplifying fibroblast-driven fibrotic signaling in aging lung. [animal-model] (novelty: 3)
- 2026-07-08 — The autophagy-senescence-inflammasome axis: A novel triad in neurodegenerative diseases?: 2026 neurodegeneration review proposes an Autophagy–Senescence–Inflammasome (ASI) axis as a self-sustaining driver of persistent neuroinflammation in brain aging and neurodegenerative disease, extending the CNS inflammaging substrate menu by naming inflammasome activation as the shared effector linking autophagic failure and glial senescence — conceptual synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-07-12 — Targeting the JAK-STAT signaling pathway ameliorates chemotherapy-induced skin aging.: 2026 preclinical study: chemotherapy-driven DNA damage engages a JAK-STAT→SASP axis in dermal fibroblasts, and ruxolitinib dampens the inflammatory secretory output while attenuating skin aging phenotypes in mice — adds a chemotherapy-skin instance to the JAK-inhibitor-as-senomorphic/anti-inflammaging roster (joining the TRF2–cGAS–STAT1 and tofacitinib-skin-explant threads). [animal-model] (novelty: 3)
- 2026-07-14 — A compendium of circulating biomarkers of senescence in humans: Insights on mechanistic impact across health domains and modulation by therapeutic interventions.: 2026 circulating-senescence-biomarker compendium reinforces the overlap between SASP output and systemic inflammatory tone, nominating GDF15 and Activin A as the most replicated cross-domain plasma indices connecting senescent-cell burden to inflammaging-adjacent clinical decline (neurodegeneration, pulmonary, cardiometabolic, musculoskeletal) — review-level synthesis, no new cytokine data. [expert-opinion] [expert-opinion] (novelty: 3)
- 2026-10-01 — The Intersection of Immunosenescence, Cellular Senescence, and Type 1 Diabetes: Paving the Way for Future Interventions.: 2026 T1D review positions chronic autoimmunity-driven inflammatory tone as both a product and accelerator of a β-cell senescence ↔ immunosenescence loop, adding T1D to the roster of autoimmune/metabolic conditions framed as inflammaging-amplifier states — synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-09-28 — Stress-Induced Senescence of Human Umbilical Cord Mesenchymal Stromal Cells Caused by Mitomycin C.: In vitro UC-MSC mitomycin C study is a negative-direction data point for the SASP arm of inflammaging: DDR-driven p53/p21/p27 arrest in perinatal MSCs occurred without classical senescent-secretory output, consistent with cell-type-specific uncoupling of growth arrest from SASP generation — no cytokine panel reported. [mechanism-plausible] (novelty: 3)
- 2026-09-29 — Autologous cytokine-induced NK cells as candidate cellular senolytics: evidence, obstacles, and the experiments still needed.: 2026 synthesis review positions autologous cytokine-induced NK cells as a candidate senolytic modality aimed at the SASP-sourced inflammaging arm, invoking NK-mediated senescent-cell clearance as an upstream dampener of chronic inflammatory tone — mechanistic proposal only, no cytokine or clearance data. [expert-opinion] (novelty: 3)
- 2026-05-23 — Chronic low-grade hippocampal inflammation blunts exercise-induced neurogenesis and alters the exercise-induced microglia transcriptome in the rat hippocampus.: 2026 adult-rat study: chronic hippocampal IL-1β inflammation impaired pattern separation, blunted exercise-induced dorsal hippocampal neurogenesis, and reshaped the exercise-induced microglial transcriptome — rat-level evidence that pre-existing neuroinflammaging acts as a ceiling on exercise-driven brain plasticity rather than a parallel axis exercise simply dampens. [animal-model] (novelty: 3)
- 2026-06-19 — Epigenetic Gene Networks Governing Immune State Transitions Across the Lifespan.: 2026 epigenetic-transition-windows framework review reframes inflammaging as a failure of reversible immune-state switching driven by age-narrowed epigenetic transition windows, repositioning chronic low-grade inflammation as a state-transition defect rather than purely excess cytokine signaling — conceptual synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-07-07 — Lactylation in the ageing nervous system: Epi-metabolic regulation, disease mechanisms, and translational challenges.: 2026 Kla-in-ageing-CNS review implicates lactate-driven lysine lactylation (notably histone H3K18la on microglial/macrophage inflammatory loci) as an epi-metabolic amplifier of neuroinflammatory programs in the ageing brain, adding a glycolysis→PTM route to the inflammaging substrate menu — narrative synthesis, no cytokine data. [expert-opinion] (novelty: 3)
- 2026-07-07 — Circulating elastin fragments drive systemic aging: Where do pro-aging elastin fragments come from? A mini-review.: 2026 mini-review nominates circulating elastin fragments released by age-related elastolysis in aorta, lungs, and skin as a discrete ECM-derived class of inflammaging mediators, extending the sterile-driver menu beyond SASP cytokines and DAMPs to peptide fragments of a structural matrix protein — synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-07-19 — The circulating senosome: Blood as the therapeutic interface of aging.: 2026 ‘circulating senosome’ review consolidates cytokines and complement/coagulation proteins alongside SASP, EVs, metabolites, cell-free nucleic acids, and microbial products as co-constituents of a single systemic signaling layer, framing inflammaging as one output of a composite blood-borne network rather than a standalone cytokine axis; synthesis, no new cytokine data. [mechanism-plausible] (novelty: 3)
- 2026-07-28 — Is amyloid beta peptide a driver of inflammaging?: 2026 narrative review nominates amyloid beta as a dual-function, context-dependent driver of brain inflammaging via cell-type-specific neuroinflammatory mechanisms, extending the CNS inflammaging substrate menu beyond microglial SASP and tau-driven astrocyte senescence to Aβ itself — synthesis only, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-08-10 — Chronic subdural hematoma through the hallmarks of aging: a geroscience framework for the commonest neurosurgical condition of older adults.: 2026 CSDH geroscience minireview nominates chronic inflammation as one of the two strongest hallmark contributors to chronic subdural hematoma pathogenesis, adding a specific neurosurgical condition of older adults to the roster of age-related diseases framed as downstream of inflammaging — review/synthesis, no new cytokine or clinical data. [expert-opinion] (novelty: 3)
- 2026-10-01 — Hepatocyte Growth Hormone Receptor Ablation Is Associated With Aging Phenotypes and Hepatic Mitochondrial Dysfunction.: Mouse hepatocyte-specific GHR knockout study: PPARγ–PDK4/CD36-driven hepatic steatosis and mitochondrial dysfunction accompanied systemic aging phenotypes, consistent with a liver-origin metabolic input to systemic inflammatory tone but without cytokine-level inflammaging readouts in the primary report. [animal-model] (novelty: 3)
- 2026-09-29 — Long-Term Human Skin Platform for Modeling Chronic Inflammation, Environmental Stress, and Therapeutic Intervention.: 2026 long-term human skin explant platform: tofacitinib suppressed IL-17/IL-22-driven chronic inflammatory programs in cultured aged human skin — ex vivo human-tissue instance of JAK inhibition dampening a cytokine arm relevant to tissue-local inflammaging, no in vivo human readout. [mechanism-plausible] (novelty: 3)
- 2026-09-30 — Lifelong Epstein-Barr virus persistence as a stress test of ageing immune surveillance: from infectious mononucleosis to chronic active EBV disease and virus-associated malignancy.: 2026 EBV review casts lifelong latent EBV antigenic drive and periodic reactivation as a chronic contributor to the inflammatory tone and hyperinflammatory syndromes of aging (CAEBV, HLH-adjacent states), positioning persistent herpesvirus-driven immune activation as one input to inflammaging distinct from sterile SASP sources — narrative synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-10-01 — Thymic Involution and Function in People With HIV and General Population Controls: A Cross-Sectional Analysis From Two Danish Cohort Studies.: 2026 Danish two-cohort cross-sectional study: higher CT-graded thymus grade associated with lower IL-6 and hs-CRP alongside greater sjTREC output and more naïve T cells — human observational evidence coupling preserved thymic soft-tissue to attenuated systemic inflammatory tone, consistent with thymic involution as an upstream contributor to inflammaging. [human-observational] (novelty: 3)
- 2026-09-28 — The effect of pectin supplementation on geriatric individuals with frailty: a randomised placebo-controlled dietary intervention study.: cross-connection with gut-microbiota-healthspan: The pectin RCT explicitly dissociates microbiota and functional improvement from circulating inflammatory biomarker change, a negative data point for the dysbiosis→inflammaging→frailty causal chain over short timeframes. (novelty: 3)
- 2026-08-12 — Clonal hematopoiesis of undetermined potential as an emerging determinant of inflammageing, and age-related diseases: Potential role as biomarker and target.: 2026 CHIP review consolidates clonal hematopoiesis of undetermined potential as an emerging determinant of inflammaging and age-related disease risk and nominates CHIP as both biomarker and candidate pharmacological prevention target, while flagging that risk models, screening, and clinical translation remain limited — synthesis of prior CH epidemiology and mechanistic literature, no new primary data. [expert-opinion] (novelty: 3)
- 2026-09-29 — Infectious diseases and sarcopenia-related phenotypes: A phenome-wide Mendelian randomization study with exploratory proteomic analysis.: 2026 phenome-wide two-sample MR screen (>2000 FinnGen endpoints vs ALM and grip strength) with exploratory proteomics: genetic liability to tonsillitis and TB sequelae associated with lower appendicular lean mass and postzoster neuralgia with higher ALM, while grip strength showed no FDR-significant infection associations — adds genetic-instrument human evidence to the infection→muscle arm of inflammaging that complements prior longitudinal-infection-burden observational signals, with phenotype specificity rather than a uniform infection–sarcopenia effect. [human-observational] (novelty: 3)
- 2026-10-01 — A Mendelian randomization study reveals TNF-β as a potential protective factor against sarcopenia.: 2026 two-sample Mendelian randomization across 91 circulating inflammatory factors identifies TNF-β as a Bonferroni-supported protective causal factor against sarcopenia traits (appendicular lean mass, grip strength, walking pace), complicating the uniform ‘inflammation = muscle loss’ framing of inflammaging by nominating a specific TNF-family cytokine with directionally protective MR evidence. [human-observational] (novelty: 3)
- 2026-07-04 — Effects of nutritional interventions on biomarkers of cellular senescence in humans: A systematic review.: 2026 systematic review of 27 human nutritional-intervention trials: calorie restriction and related dietary strategies most consistently reduce SASP/inflammatory senescence biomarkers in humans, giving human-trial-level support that nutrition’s measurable anti-aging signal in people lands on the inflammaging arm rather than on cell-abundance readouts. [human-rct] (novelty: 3)
- 2026-07-13 — PFDA exposure promotes myocardial aging and fibrosis via hyperactivation of the MTORC1 signaling axis.: 2026 preclinical PFDA (perfluorodecanoic acid) study implicates cardiomyocyte inflammation as part of a mitochondrial-dysfunction/MTORC1-hyperactivation/senescence axis driving myocardial fibrosis — extends the environmental-pollutant inputs to cardiac tissue inflammaging to include a specific PFAS compound. [animal-model] (novelty: 3)
- 2025-12-05 — The immuno-neurological axis: association between autoimmune diseases and dementia risk.: 2026 Korean national cohort (~8.7M person-years): autoimmune disease diagnosis associated with ~32% higher dementia risk (especially Alzheimer’s) and higher odds of positive cognitive-impairment screening, adding large-scale human-observational weight to the autoimmunity → chronic systemic inflammation → neurodegeneration arm of inflammaging — association only, no cytokine or mechanistic measurement. [human-observational] (novelty: 3)
- 2026-01-25 — Targeted delivery of senolytic drugs using macrophage membrane-camouflaged magnetic nanoparticles inhibits endplate sclerosis.: 2026 LSI-mouse study: clearing senescent-like endplate macrophages with membrane-camouflaged magnetic nanoparticle-delivered ABT-263 dampened IL-10-driven angiogenesis–osteogenesis coupling and endplate sclerosis, framing local macrophage SASP (notably IL-10 skew) as a tissue-specific inflammaging substrate in degenerating spinal endplates. [animal-model] (novelty: 3)
- 2026-05-19 — High cardiorespiratory fitness is associated with younger brain age: the role of systemic inflammation.: 2026 UK Biobank midlife cross-sectional analysis: high cardiorespiratory fitness associated with younger MRI brain-age, with lower systemic inflammation statistically mediating ~21% of the association — human-scale quantification of inflammaging as a partial mechanistic bridge between fitness and brain-aging readouts. [human-observational] (novelty: 3)
- 2026-10-01 — A Deep-Learning Based Biomarker of Systemic Cellular Senescence Burden to Predict Mortality and Health Outcomes.: cross-connection with cellular-senescence: The circulating SASP Score formalizes a plasma-protein readout bridging senescent-cell burden and inflammaging, giving the two mechanisms a shared human quantification tool. (novelty: 4)
- 2026-10-01 — Traditional Chinese Medicine Formulas in Delaying Aging: From Theoretical Foundations to Molecular Mechanisms and Translational Perspectives.: 2026 TCM-formulas-and-aging review positions multi-component dampening of chronic low-grade inflammation as a shared downstream axis of TCM anti-aging activity, aggregating preclinical formula effects without cytokine-level human trial data. [expert-opinion] (novelty: 3)
- 2026-09-24 — Targeting Glial Glycolysis with EGCG Alleviates Parkinson’s Disease in a PINK1 mutant Drosophila Model.: Drosophila PINK1-mutant PD study: glial glycolytic upregulation and secreted lactate drive neuroinflammation upstream of dopaminergic loss, and EGCG dampens this axis — adds a glia-metabolism-to-lactate route into tissue-local neuroinflammaging in a genetic mitophagy-failure model, fly-only. [animal-model] (novelty: 3)
- 2026-09-12 — Soluble pathogenic tau transmission to astrocytes drives acute oxidative damage, cellular senescence, and neurovascular uncoupling in a model of Alzheimers tauopathy: 2026 tauopathy-model preclinical study nominates astrocyte SASP triggered by intracellular tau oligomer uptake as a tissue-local source of neuroinflammatory tone in tauopathy, extending the SASP-driven inflammaging concept to astrocytes and tying it to neuronal structural loss and neurovascular uncoupling. [animal-model] (novelty: 3)
- 2026-09-17 — Ecosystem Nourishment for Gut Restoration After Fecal Transplantation: 2026 four-arm RCT protocol (adults ≥40) proposes young-donor FMT ± fermented high-fiber diet as a combined lever against inflammatory and biological aging markers, positioning gut-directed rejuvenation as a candidate anti-inflammaging modality — protocol only, no cytokine or clock readout yet. [human-rct] (novelty: 3)
- 2026-09-14 — The Effect of Oral SPM Supplementation on INflammation-induced Vascular Ageing in Obese Hypertensive Patients: 2026 early-phase RCT protocol (n=60, obese hypertensives with high residual CV risk) will test whether oral specialized pro-resolving mediator (SPM) supplementation dampens systemic inflammation and improves immune/metabolic readouts — first hypothesis-testing human trial framing ‘failed resolution’ rather than excess inflammatory drive as the tractable arm of inflammaging in cardiometabolic disease; protocol only, no results. [human-rct] (novelty: 3)
- 2026-09-23 — Therapeutic Immune Reprogramming by Rapamycin Attenuates Plaque Inflammation and Lymphoid Immune Responses in Aged Atherosclerotic Mice: 2026 aged atherosclerotic mouse study: rapamycin dampened plaque and lymphoid inflammatory activity in aged Apoe-context mice, offering a tissue-local mTOR-inhibition instance of anti-inflammaging action at the arterial wall. [animal-model] (novelty: 3)
- 2026-09-12 — Age-related IGF-1 decline permits a redox-sensitive transcriptional shift that directs hematopoiesis toward a CCR2myeloid fate.: Preclinical mechanistic report links a decline in bone-marrow IGF-1 to NF-κB-driven transcriptional reprogramming of HSCs toward a CCR2+ myeloid fate, offering a stem-cell-origin route by which the myeloid skew of aging hematopoiesis feeds sterile inflammatory tone — no cytokine or human readout. [animal-model] (novelty: 3)
- 2026-09-18 — Frailty of older patients is not reflected in the melanoma tumor microenvironment and treatment response to immune checkpoint blockade therapy.: 2026 melanoma IMC study (n=23) found frailty status did not broadly reshape the pretreatment tumor immune microenvironment in older patients, offering a negative tissue-local signal against the assumption that systemic inflammaging/frailty uniformly degrades tumor-site immune milieu — small n, no cytokine panel. [human-observational] (novelty: 3)
- 2026-09-19 — 3D-Printed and Biofabricated Scaffolds for Osteoporotic Bone Defect Repair: Mechanical Adaptation, Redox Control, Senescence Modulation and Osteoimmunomodulation.: 2026 scaffold review frames the aged osteoporotic bone microenvironment as a local inflammaging niche where SASP and skewed macrophage polarization impair osseointegration, positioning osteoimmunomodulatory scaffold cargos as candidate dampeners of tissue-local inflammatory tone — synthesis of preclinical scaffold literature, no cytokine data. [expert-opinion] (novelty: 3)
- 2026-09-25 — Longitudinal proteomic organ-specific aging in heart failure.: 2026 longitudinal proteomic-organ-age study in heart failure: accelerating multi-organ proteomic aging precedes adverse events, with the immune organ age gap among predictors independent of NT-proBNP and troponin T — extends immune-compartment inflammaging signatures from cross-sectional risk markers to a longitudinal pre-event trajectory in HF. [human-observational] (novelty: 4)
- 2026-09-18 — Associations of single and combined exposure to plasma metals with biological aging in Chinese adults: Mediation by inflammation and oxidative stress and moderation by diabetes.: 2026 Chinese cross-sectional plasma-metals study (n=3055) reports inflammation biomarkers partially mediating the association between single/mixed plasma metal exposures (Cu, Se, Sb) and multiple biological-age acceleration metrics — positions systemic inflammation as a downstream amplifier of environmental metal exposure in accelerated aging. [human-observational] (novelty: 3)
- 2026-09-23 — Periodontitis, Edentulism, and Accelerated Biological Aging: A Population-Based Study of Epigenetic Clocks.: 2026 NHANES analysis ties staged periodontitis and edentulism to multi-clock epigenetic age acceleration in older U.S. adults, providing population-scale human observational support for the oral-dysbiosis→systemic-inflammaging→biological-age-acceleration chain (association only, no cytokine measurement). [human-observational] (novelty: 3)
- 2026-09-15 — Common and distinct plasma proteomic signature of aerobic and motor physical activity interventions and their link to episodic memory.: 2026 secondary analysis of a 12-week RCT (n=34, healthy older adults): aerobic and gross-motor exercise share a 24-protein inflammatory plasma signature, extending exercise-as-anti-inflammaging evidence from cytokine panels to a modality-shared proteomic signature at small-sample resolution. [human-rct] (novelty: 3)
- 2026-09-16 — Sex-specific biological aging clocks across organs and omics.: 2026 sex-specific organ-aging clocks study finds female–male divergence in organ-resolved proteomic aging networks including inflammation-relevant compartments across 15 organ systems, implying inflammaging protein signatures (e.g., PIS-type composites) may carry sex-differential predictive weight not captured by pooled models — descriptive human observational. [human-observational] (novelty: 4)
- 2026-09-16 — Retrotransposable element derepression distinguishes DNMT3A-mutant from TET2-mutant clonal haematopoiesis.: Human observational CH profiling: DNMT3A high-VAF clones carry a distinctive RTE-driven TNF-α/NF-κB + interferon + senescence inflammatory signature absent in TET2 clones, refining CH’s contribution to inflammaging as mutation-specific rather than uniform. [human-observational] (novelty: 3)
- 2026-09-15 — Cuproptosis in age-related orthopedic diseases: mechanisms and therapeutic prospects.: 2026 cuproptosis-in-orthopedic-aging review frames copper-triggered mitochondrial cell death as a DAMP source that plausibly feeds joint, bone, and disc inflammatory tone in OA, OP, and IVDD, extending the metal-dyshomeostasis→sterile inflammation menu to skeletal tissues — conceptual only, no cytokine data. [expert-opinion] (novelty: 3)
- 2026-09-14 — MA-5 attenuates disease-associated transcriptomic aging and pathological microglial states in Gaucher disease.: Preclinical Gaucher study: MA-5 suppressed cGAS–STING/NLRP3-driven microglial inflammation, prolonged survival, and reversed a disease-associated accelerated transcriptomic aging signature — a compound-level demonstration that dampening a specific mtDNA→DNA-sensing/inflammasome node can rewind a transcriptomic aging readout in a neuroinflammatory disease model. [animal-model] (novelty: 3)
- 2026-09-25 — The Interplay of Metabolic Dysfunction, Neuroinflammation, and Mitochondrial Dysfunction in Balance Impairment: Insights from Type 2 Diabetes Mellitus and Alzheimer’s Disease.: 2026 review frames NLRP3-driven neuroinflammation as the inflammatory node in a shared T2DM–Alzheimer’s cycle with glucotoxicity/insulin resistance and mitochondrial failure, linking inflammaging output specifically to balance impairment and motor-circuit degeneration; conceptual synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-09-17 — Stress and cancer from an integrative psychoneuroimmunology perspective: Neurobiological mechanisms and clinical implications.: 2026 stress–cancer psychoneuroimmunology review frames chronic HPA-axis and sympathetic activation as a systemic amplifier of pro-inflammatory tone and tumor-microenvironment inflammation, positioning sustained psychosocial stress as a candidate upstream driver of inflammaging in cancer patients; narrative synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-09-20 — Panvascular aging: The pioneer organ hypothesis, research models and future directions.: 2026 panvascular-aging ‘pioneer organ’ review nominates the aged vasculature as an upstream, whole-body distributor of inflammaging signals via circulating SASP factors and endothelial-/VSMC-derived extracellular vesicles, framing systemic low-grade inflammation as partly vasculature-sourced rather than diffuse — conceptual synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-09-23 — Engineered Extracellular Vesicle Revitalizing Macrophage Energy Metabolism for Aged Wound Repair.: 2026 mouse wound-healing study: 4OI-engineered EVs dampen local wound-macrophage inflammatory dysfunction by reinstating ASS1/arginine–OXPHOS metabolism, framing macrophage energy-metabolism collapse as a targetable local inflammaging substrate in aged and diabetic skin — preclinical, no cytokine or outcome data in humans. [animal-model] (novelty: 3)
- 2026-09-24 — The mechanisms and mechanics of aging.: 2026 mechanics-of-aging review nominates ECM stiffening and mechanotransduction failure as an upstream mechanical substrate feeding chronic sterile inflammation via SASP and altered stromal–immune force signaling, adding a matrix-mechanics origin to the menu of inflammaging drivers — conceptual synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-09-25 — Type 2 Angiotensin II receptor (AT2R) deficiency exacerbates cardiac senescence and fibrosis in aging mice.: 2026 aged-mouse AT2R knockout study: AT2R loss activates cardiac NLRP3-inflammasome signaling and SASP in parallel with fibrosis and ~5-month shorter median lifespan, nominating a RAS receptor-level counter-regulatory node whose failure feeds cardiac tissue inflammaging. [animal-model] (novelty: 3)
- 2026-09-21 — Senescent Cell Heterogeneity: Tissue-Dependent Signatures and Age Dynamics Revealed by Human scRNA-Seq Data.: 2026 human multi-tissue scRNA-seq map extends the inflammaging substrate by cataloging tissue-specific SASP programs and ligand-receptor interactions between senescent cells and their microenvironment across five organs, offering a cell-resolved picture of where sterile inflammatory output originates — descriptive only, no cytokine or outcome data. [human-observational] (novelty: 3)
- 2026-09-14 — Cardiovascular frailty - an emerging frailty phenotype.: 2026 narrative review introduces ‘oxi-inflammaging’ as one of three integrated pillars of a proposed cardiovascular frailty phenotype, positioning inflammaging (with oxidative stress) as a defining mechanism for a frailty subtype rather than a downstream correlate — framing contribution, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-09-15 — The Oral Microbiome-Inflammaging Axis in Elderly Periodontitis: Emerging Immunopathogenic and Systemic Mechanisms.: 2026 narrative review nominates elderly periodontitis as a geroscience-relevant local-to-systemic inflammaging generator, in which oral dysbiosis plus immunosenescence/cellular senescence sustain inflammatory tone that persists after periodontal therapy and contributes to frailty-like phenotypes — synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-09-15 — Lymphatic rarefaction drives cardiac inflammaging.: 2026 preclinical report (title-level) nominates cardiac lymphatic rarefaction as an upstream driver of cardiac inflammaging, adding impaired lymphatic clearance of immune cells and mediators to the growing menu of tissue-local inflammaging origins in the aging heart — no abstract-level cytokine or density data available. [animal-model] (novelty: 3)
- 2026-09-16 — Immunosenescence and immune-organ axis dysfunction: Potential of algal bioactives and nutritional interventions for healthy ageing.: 2026 algal-bioactives review nominates marine-derived compounds and nutritional interventions as anti-inflammaging levers acting through inflammation resolution and immune-organ axis modulation — narrative synthesis, no cytokine or trial data. [expert-opinion] (novelty: 3)
- 2026-09-20 — CSenescence-associated-secretory phenotype proteins and inflammatory pathways are involved in psychosis: A transdiagnostic study using the Human Connectome Project for early psychosis (HCP-EP) data.: 2026 HCP-Early Psychosis proteomic study: early psychosis is associated with enrichment of TNF-response and monocyte-chemotaxis inflammatory pathways alongside an elevated SASP index, offering a human transdiagnostic proteomic instantiation of inflammaging in a psychiatric population and linking systemic inflammatory tone to BMI and psychological well-being — cross-sectional, no cytokine trial data. [human-observational] (novelty: 3)
- 2026-09-21 — A two-step model of age-associated autoreactivity: B cell-intrinsic aging meets inflammaging.: 2026 hypothesis-driven review proposes a two-step model in which inflammaging is the second-step amplifier that selectively expands intrinsically tolerance-eroded autoreactive B-cell subsets (ABCs/DN2) in older adults, extending inflammaging’s downstream consequences from generic tissue inflammation to a specific mechanism for age-related autoimmunity — synthesis, no new cytokine or B-cell frequency data. [expert-opinion] (novelty: 3)
- 2026-09-16 — Aging as Loss of Biological Self-Correction: A Geroscience Framework for Longevity, Inflammaging, and Restored Resilience.: 2026 self-correction framework review reframes inflammaging as failed termination/resolution of inflammatory perturbations rather than a standalone driver, subsuming it under a broader recovery-trajectory account of aging; conceptual synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-09-21 — Why Some People Live Past 100: The Role of the Immune System in Centenarians, Semi-Supercentenarians and Supercentenarians.: 2026 centenarian immunology review frames extreme longevity as compatible with — and dependent on — better-regulated inflammaging (attenuated chronic inflammatory tone alongside preserved cytotoxic effector capacity) rather than absence of age-related inflammatory drift, adding an extreme-longevity endpoint to the inflammaging concept; synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-09-26 — Plasma and cerebrospinal fluid proteomics reveal distinct patterns of senescence and neuropathology in aging rhesus macaques.: 2026 rhesus macaque plasma+CSF proteomic study identifies human-like inflammaging protein signatures with distinct plasma vs CSF compartment patterns across the lifespan, offering an NHP substrate for testing peripheral–CNS inflammaging crosstalk beyond cytokine panels. [animal-model] (novelty: 3)
- 2026-09-21 — Plasma inflammatory markers and brain white matter microstructure in late middle-aged and older adults.: 2026 cross-sectional human study (n=457 dementia-free late middle-aged/older adults): higher plasma pro-inflammatory markers (cytokine composite, CRP, GFAP) associated with altered white-matter microstructure on multi-shell NODDI and conventional dMRI, independent of plasma AD biomarkers — extends peripheral inflammaging signatures to a brain-tissue imaging readout beyond cytokine panels alone. [human-observational] (novelty: 3)
- 2026-09-24 — Impact of supervised physical exercise on inflammatory and oxidative stress biomarkers in older adults: a systematic review and meta-analysis of randomized controlled trials.: 2026 meta-analysis of 50 RCTs (n=4,379, adults ≥65) of supervised exercise: modest but significant reductions in CRP/hs-CRP and increases in anti-inflammatory IL-10, with inconsistent effects on IL-6 and TNF-α — human-RCT-level consolidation that exercise dampens some but not all canonical inflammaging cytokines in older adults. [human-rct] (novelty: 3)
- 2026-09-23 — Multidimensional Aging Trajectories Preceding Cardiovascular Events.: 2026 ASPREE nested case-control does not measure cytokines directly but shows frailty and intrinsic capacity — phenotypes previously tied to inflammaging protein signatures (IL-6, CXCL9, TNFRSF11B) — diverge from CVD-free controls up to a decade before events, extending the temporal reach of inflammaging-adjacent functional readouts as pre-CVD signals. [human-observational] (novelty: 3)
- 2026-05-15 — Jintiange ameliorates age-related sarcopenia by inhibiting the cGAS-STING signaling pathway via maintaining mitochondrial homeostasis.: 2026 aged-mouse Jintiange study: oral TCM formulation dampens skeletal-muscle cGAS–STING/NF-κB inflammatory tone by restoring mitochondrial homeostasis, with muscle-strength and endurance benefits persisting after withdrawal — adds a compound-level anti-inflammaging lever specifically in aging muscle. [animal-model] (novelty: 3)
- 2026-09-18 — Ferroptosis and Ferro-Aging in Obesity: Bibliometric Mapping, Shared Mechanisms, and Translational Perspectives.: 2026 obesity–ferroptosis review frames the pro-ferroperoxidative adipose microenvironment as a lipid-peroxide/DAMP source feeding chronic low-grade inflammation in obese aging, linking iron-driven lipid peroxidation to inflammaging tone via oxidized-lipid signaling — narrative synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-09-22 — Effects of anti-aging diets and exercise on age-related musculoskeletal diseases via gut microbiota modulation.: 2026 diet–exercise–musculoskeletal review positions dampening of gut-derived LPS translocation and consequent systemic low-grade inflammation as the shared inflammaging arm through which anti-aging diets and moderate exercise plausibly modify bone, joint, and muscle aging — synthesis of preclinical/small-human evidence, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-09-18 — Selenium Deficiency is a Significant Risk Factor for Sarcopenia: Evidence and Selenoprotein-Mediated Mechanisms.: 2026 selenium–sarcopenia review invokes selenoprotein-mediated inflammation resolution (SELENOP, SELENOW) as one arm by which selenium status modulates the muscle-local inflammatory tone contributing to inflammaging, based on consolidated epi/clinical/animal evidence — no direct cytokine RCT. [human-observational] (novelty: 3)
- 2026-09-18 — Imeglimin provides dual hepatic and skeletal muscle protection in experimental MASH-associated sarcopenia.: MASH-sarcopenia mouse study: imeglimin attenuated hepatic injury in a MASH context alongside muscle preservation, indirectly compatible with dampened liver–muscle inflammatory crosstalk, but cytokine-level inflammaging endpoints were not the primary readout. [animal-model] (novelty: 3) [animal-model] (novelty: 3)
- 2026-06-01 — Adipose tissue as a systemic modulator of brain aging: mechanistic links between metabolism, inflammation and neurodegeneration.: 2026 adipose–brain aging review positions visceral adipose SASP, adipokine imbalance, and adipose-derived vesicles as a discrete peripheral source feeding CNS inflammaging and neurodegenerative risk, while subcutaneous/thermogenic depots are framed as neutral-to-protective — narrative synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-09-13 — FABP3 regulates vascular remodeling and endothelial-mesenchymal transition through NF-κB activation in aged mice fed a high-fat diet.: 2026 aged-HFD mouse carotid study: FABP3-driven NF-κB activation is proposed as the local inflammatory substrate coupling combined aging and diet-induced obesity to endothelial inflammation and EndMT — adds a lipid-binding-protein upstream node to vascular inflammaging. [animal-model] (novelty: 3)
- 2026-09-18 — Lifelong Caloric Restriction Reshapes Age-Related Hepatic Oxylipin Profiles and Is Associated with a CYB5R3-Linked Epoxide-Diol Signature.: 2026 mouse hepatic oxylipin profiling: lifelong caloric restriction blunted the mid-life pro-inflammatory oxylipin surge in liver and preserved CYP-derived epoxy-fatty acids, offering a lipid-mediator-level substrate for the anti-inflammaging effect of CR distinct from cytokine-centric readouts. [animal-model] (novelty: 3)
- 2026-09-14 — GLP-1 receptor agonists, epigenetic aging, and the prospect of pharmacological healthspan extension.: 2026 review consolidates GLP-1 receptor agonist RCT mortality and inflammation signals that exceed what weight/glycemic lowering predicts, framing GLP-1R engagement as a pharmacologic dampener of systemic inflammaging tone alongside epigenetic-clock deceleration. [human-rct] (novelty: 3)
- 2026-09-15 — Radiation-induced atrial fibrillation is driven by cellular senescence via the GATA4 - NF-κB pathway and rescued by D/Q senolytic therapy.: 2026 mouse radiation-AF study: GATA4–NF-κB-driven atrial SASP is proposed as the local inflammatory substrate of radiation-induced atrial remodeling and arrhythmogenesis, with D+Q senolytics dampening the phenotype — a tissue-local inflammaging instance in the atrium responsive to senescent-cell clearance. [animal-model] (novelty: 3)
- 2026-09-11 — Dendritic Cell Antigen Presentation Enables T Cells to Enter the Brain and Contribute to Tau Pathology: News-reported preclinical work adds dendritic-cell-licensed T-cell brain infiltration to microglial inflammation and BBB leak as a proposed contributor to CNS inflammaging in tauopathy — mechanistic framing, no cytokine data. [mechanism-plausible] (novelty: 3)
- 2026-09-09 — The redox architecture of gestational diabetes mellitus: from cellular stress engine to epigenetic and mitochondrial rewiring.: 2026 GDM redox review casts gestational diabetes as a systemic redox+inflammatory state that accelerates maternal biological aging trajectories, invoking chronic low-grade inflammation from placental oxidative stress as one arm of the persistent post-pregnancy aging signature — narrative synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-09-10 — Mitochondria-targeted esculetin mitigates age-associated cardiac remodeling through coordinated activation of AMPK-SIRT1 and inhibition of p38 MAPK signaling.: 2026 ApoE mouse cardiac-remodeling study: mitochondria-targeted esculetin dampens cardiac inflammatory markers alongside senescence and fibrosis via AMPK–SIRT1 activation and p38 MAPK inhibition, adding a mitochondria-directed natural-product route into cardiac inflammaging with metformin-comparable effects — preclinical only. [animal-model] (novelty: 3)
- 2026-08-28 — Senescent cells maintain viability through adhesion-dependent fragmentation that promotes debris deposition.: 2026 preclinical study proposes SCAF rupture as a physical mechanism for extracellular deposition of DAMPs and amyloid-like material from senescent cells, offering a debris-based substrate for the sterile inflammatory tone attributed to inflammaging beyond secreted SASP cytokines. [mechanism-plausible] (novelty: 4)
- 2026-09-09 — Canonical complement C3a-C3AR1 signalling in ageing and age-related disease: Cellular mechanisms, tissue-specific effects and translational challenges.: 2026 C3a–C3AR1 review nominates canonical extracellular complement C3a–C3AR1 signalling (complementing the earlier intracellular complosome framing) as a discrete tissue-context amplifier of inflammaging via macrophage/microglial reprogramming in adipose and neurovascular niches — narrative synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-09-10 — Mitochondrial homeodynamics in ageing: mechanisms, resilience, and interventions.: 2026 mitochondrial-homeodynamics review frames inflammaging as a downstream consequence of failed mitochondrial recovery capacity (mtDNA leakage, chronic ROS) rather than a primary driver — synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-09-12 — Influenza vaccination as a modulator of inflammaging: trained tolerance as a mechanistic lens on heterologous effects in age-related diseases.: 2026 review reframes influenza vaccination’s heterologous cardiovascular, neurodegenerative, and cardio-renal benefit signals as persistent myeloid epigenetic remodeling (trained tolerance) that dampens inflammaging tone — narrative synthesis of epidemiological, murine causal, and single-cell multiomic evidence, no new primary human data. [expert-opinion] (novelty: 3)
- 2026-09-12 — Proteomic signatures of systemic inflammation in aging, multimorbidity, and mortality.: UK Biobank proteomic study derives a compact Proteomic Inflammaging Score (PIS) anchored to six inflammatory biomarkers that outperforms conventional inflammatory markers and aging clocks for predicting all-cause mortality and multimorbidity — a measurement upgrade for inflammaging as a quantifiable population-scale exposure rather than a mechanistic advance. [human-observational] (novelty: 3)
- 2026-09-10 — EXPRESS: Rapamycin increases cerebral blood flow and modulates metabolic, inflammatory, and microbiome profiles in healthy middle-aged APOE4 carriers: a pilot single-arm trial.: Pilot single-arm rapamycin trial (1 mg/day × 4 weeks, APOE4 carriers) reports modulation of systemic inflammatory profile alongside cerebrovascular and metabolic changes — small, uncontrolled human signal consistent with mTOR-inhibition dampening inflammaging tone. [human-rct] (novelty: 3)
- 2026-09-11 — Mitochondrial homeostasis in musculoskeletal diseases: From pathogenic mechanisms to precision therapies.: 2026 musculoskeletal-mitochondria review frames mtDNA leakage and mitochondrial ROS as upstream drivers of the joint- and bone-tissue inflammatory tone in OA and RA, situating mitochondria-targeted antioxidants and senolytics as candidate anti-inflammaging levers in musculoskeletal disease — narrative synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-08-24 — Qinghuang powder ameliorates cellular senescence and energy metabolism abnormalities in bone marrow mesenchymal stem cells of myelodysplastic syndromes.: 2026 MDS-BMMSC in vitro study: Qinghuang powder components dampened SASP output in patient-derived stromal cells, nominating the marrow niche as a tissue-local SASP source in myelodysplastic syndromes and TCM as a candidate SASP modulator — cell-culture only, no cytokine data in humans. [mechanism-plausible] (novelty: 3)
- 2026-07-17 — Cellular Senescence and COVID-19 Long-Hauler Syndrome: cross-connection with cellular-senescence: Post-viral SASP is nominated as an upstream driver of the sustained low-grade inflammation profile described in Long COVID, tying acute-infection-triggered senescence to inflammaging biology. (novelty: 3)
- 2026-09-10 — NAD+ Metabolic Reprogramming Drives CD8+ T Cells Senescence and Exacerbates Ulcerative Colitis: Already logged 2026-09-01 — NAD-loss-driven CD8 T-cell senescence with mtDNA–cGAS–STING signaling nominated as a tissue-local inflammaging driver in ulcerative colitis (mouse causal + human disease-severity / anti-inflammatory non-response correlations; senolytic rescue in mice). [animal-model] (novelty: 3)
- 2026-09-01 — NADMetabolic Reprogramming Drives CD8T Cells Senescence and Exacerbates Ulcerative Colitis.: 2026 UC study nominates NAD-loss-driven CD8 T-cell senescence with mtDNA–cGAS–STING signaling as a tissue-local inflammaging driver in ulcerative colitis, with human correlations to disease severity and anti-inflammatory non-response and senolytic rescue in mice. [animal-model] (novelty: 3)
- 2026-08-14 — Targeting TWEAK to enhance mitochondrial biogenesis and attenuate age-related muscle mass loss.: Aged-mouse TWEAK knockdown study: silencing the TWEAK/Fn14 cytokine axis in skeletal muscle suppresses p38 MAPK signaling and inflammatory cytokine output alongside attenuated muscle mass loss, nominating TWEAK as a muscle-tissue inflammaging node — preclinical, grip strength unchanged. [animal-model] (novelty: 3)
- 2026-07-29 — Aging Resilience Through Microbiota Optimization and Regulation: Planned FMT-from-young-active-donors trial positions restored microbial diversity as a candidate upstream lever on age-related functional decline, implicitly targeting the dysbiosis→inflammaging arm — protocol only, no cytokine readout. [human-rct] (novelty: 3)
- 2025-11-22 — Exploring the role of β2-microglobulin in the relationship between physical activity and DNAm-predicted PhenoAge: Evidence from a population-based and mice single-cell RNA-sequencing study.: 2026 U.S. cohort mediation analysis nominates circulating β2-microglobulin as a substantial (~38%) mediator between physical activity and DNAm-PhenoAge, adding an immune-derived circulating protein to the menu of inflammaging-adjacent mediators linking exercise to biological-age readouts. [human-observational] (novelty: 3)
- 2026-03-17 — Gut Microbiota Resilience and Environmental Stressors: A Hidden Key to Lifespan Optimization?: 2026 gut microbiota resilience review positions loss of microbial resilience under environmental stress as an upstream contributor to chronic low-grade inflammatory tone, framing resilience-restoring interventions as candidate anti-inflammaging levers — narrative synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-04-13 — The metabolic-inflammatory axis in aging: A multi-organ framework anchored in Sarcopenia - A review.: 2026 GLAM-framework review positions inflammaging as a systemic output of sarcopenia-anchored gut–liver–adipose–muscle crosstalk, with insulin resistance and mtROS–p53 signaling as tissue-spanning amplifiers — narrative synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-04-15 — Dietary geroprotective peptides: structural determinants, AI-driven discovery, and synthetic biology production for healthy ageing.: 2026 dietary-peptide review invokes Nrf2 engagement by food-derived bioactive peptides as an antioxidant/anti-inflammatory lever plausibly dampening inflammaging tone; conceptual framing only, no cytokine data. [expert-opinion] (novelty: 3)
- 2026-05-30 — Cell senescence in chronic pain: An integrative perspective on cellular and neural mechanisms.: 2026 review frames chronic pain as a clinical manifestation of localized/systemic inflammaging fed by SASP from senescent neural, glial, and immune cells, positioning senolytics and SASP modulators as candidate pain-modifying anti-inflammaging strategies — narrative synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-06-03 — Senolytics ameliorate cognitive decline in D-galactose-induced aging mice by inhibiting astrocytic cholesterol accumulation.: 2026 D-gal mouse study: D+Q senolytics reduced astrocyte cholesterol accumulation and downstream neuroinflammatory markers alongside cognitive rescue, nominating astrocytic sterol biosynthesis as an upstream metabolic input to CNS inflammaging in an accelerated-aging model. [animal-model] (novelty: 3)
- 2026-06-12 — Chimeric Antigen Receptor T Cells as Living Therapeutics Targeting Senescence and Age-Related Diseases.: 2026 CAR T senolytics review positions antigen-targeted senescent-cell clearance as a potentially more durable route to dampening SASP-driven systemic inflammation than repeat-dose small-molecule senolytics, but flags that preclinical fibrosis/metabolic-reversal data have not yet been translated to human cytokine or outcome endpoints. [expert-opinion] (novelty: 3)
- 2026-06-22 — Age-related metabolomic signatures and stroke susceptibility in a population-based cohort.: 2026 Chinese cohort NMR metabolomics: triglyceride-enriched lipoprotein and low-molecular-weight metabolite signatures partially mediate age–stroke risk, indirectly compatible with lipid-driven vascular inflammatory tone but not itself a cytokine or SASP measurement — trend-signal only for the metabolic arm of inflammaging. [human-observational] (novelty: 3)
- 2026-06-12 — Hematopoietic Rejuvenation via Natural Senolytic NSPCC1 Delays Inflammatory Aging.: 2026 mouse study: oral NSPCC1 senolytic reduced multi-organ inflammatory aging phenotypes alongside lifespan extension in two aging models, consistent with senescent-cell clearance dampening systemic inflammaging tone in aged mice — no cytokine-level human data. [animal-model] (novelty: 3)
- 2026-06-27 — Co-exposure to environmental lead and hypertension exacerbates anxiety and depression via mtDNA-mediated cGAS phase separation.: 2026 mouse co-exposure study: lead + hypertension amplifies mtDNA–cGAS–driven inflammatory senescence in prefrontal astrocytes, extending inflammaging substrates to an environmental toxicant × cardiometabolic comorbidity interaction with behavioral (anxiety/depression) readouts. [animal-model] (novelty: 3)
- 2026-04-30 — Damage-induced muscle regeneration after exercise in humans: Modulatory effects of ginsenoside Rg1.: 2026 ginsenoside Rg1 review positions Rg1’s putative senolytic action on damaged skeletal muscle as an anti-inflammaging lever in the exercise-injury context, alongside reduced perceived exertion in human trials; synthesis, no new cytokine data. [expert-opinion] (novelty: 3) [expert-opinion] (novelty: 3)
- 2026-07-01 — The Molecular Basis of Ocular Aging: Mechanisms, Pathologies, and Emerging Therapeutics.: 2026 ocular-aging review implicates SASP-driven local inflammation in RPE, trabecular meshwork, and neurovascular-unit degeneration as one downstream output of converging aging hallmarks in the eye, framing anti-inflammaging strategies as adjuncts to standard ocular therapies — conceptual synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-07-11 — From local to systemic: Spinal aging in the multi-organ aging network.: 2026 spinal-aging review positions systemic inflammaging (and disc/paraspinal SASP spillover) as one mechanistic axis linking degenerative spinal disease to whole-body aging, motivating anti-inflammaging strategies as adjuncts to lesion-focused spine care — conceptual synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-07-16 — Vitamin C attenuates primate bone marrow aging at the molecular and progenitor level.: 2026 primate vitamin C study: rebalancing of HSPC lineage output away from myeloid bias offers an indirect upstream lever on the myeloid-skewed immune output implicated in inflammaging, though cytokine-level inflammatory readouts were not the primary endpoint. [animal-model] (novelty: 4)
- 2026-07-16 — Age-associated decline of Lamtor5 drives immunosenescence and systemic aging via cGAS-mediated paracrine inflammation.: 2026 mouse study nominates age-related macrophage Lamtor5 decline → failed ESCRT-mediated cGAS degradation → cGAS–STING-driven paracrine inflammation as a discrete molecular substrate of systemic inflammaging, with macrophage cGAS blockade or senolytics attenuating multi-organ aging endpoints. [animal-model] (novelty: 3)
- 2026-07-17 — Manganese overload as a previously underappreciated trigger of cellular senescence: Unraveling mechanisms and therapeutic rescue by the senolytic quercetin.: 2026 C. elegans + PC12 study links manganese overload to STING-related signaling and a senescence program plausibly feeding inflammatory tone, framed as an environmental-metal exposure route into the DNA-sensing arm of inflammaging; quercetin dampens the response in models. [animal-model] (novelty: 3)
- 2026-07-20 — Theca cells: active orchestrators of ovarian aging.: 2026 theca-cell review nominates theca-derived SASP as a compartment-specific contributor to ovarian inflammaging that feeds follicular atresia and fibrosis — conceptual synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-08-01 — Ammonia Metabolism in the Aging Liver: Emerging Mechanistic Insights.: 2026 hepatic-ammonia review implicates impaired hepatic ammonia disposal as an upstream contributor to systemic inflammaging via senescence-linked hepatic SASP and multi-organ (brain, muscle, gut) spillover — conceptual synthesis, no new cytokine data. [mechanism-plausible] (novelty: 3)
- 2026-07-29 — Complosome as a key modulator of cellular senescence, aging and age-related diseases.: 2026 complosome review frames intracellular complement (intC3/intC5) as a cell-intrinsic amplifier of NF-κB-driven inflammatory tone contributing to inflammaging, distinct from canonical extracellular complement activation — narrative synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-07-15 — Osteoimmune senescence in aging-related bone diseases.: 2026 osteoimmune-senescence review frames skeletal-cell SASP plus impaired immune clearance as a bone-compartment contribution to systemic inflammaging that reciprocally corrodes remodeling and repair — conceptual synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-07-31 — The Physical Senotype in cellular senescence: Mechanical and physical strategies for senotherapy.: 2026 Physical Senotype review posits that mechanical reprogramming or clearance of senescent cells could dampen SASP-driven inflammaging as a downstream consequence, extending the anti-inflammaging toolkit beyond pharmacologic senolytics/senomorphics — conceptual only, no cytokine data. [expert-opinion] (novelty: 3)
- 2026-07-31 — Haploidentical Hematopoietic Stem Cell Transplantation Drives Time-dependent premature T Cell Senescence: Recipient Microenvironment Modulates Donor T Cell Epigenetic Aging, Telomere Homeostasis and SASP Remodeling.: 2026 haplo-HSCT human comparative study: SASP remodeling in donor-derived T cells post-transplant tracks with recipient age, framing HSCT as an accelerator of T-cell-derived inflammaging modulated by the aged recipient microenvironment. [human-observational] (novelty: 3)
- 2026-08-03 — Aging at the neurovascular interface: An integrative framework linking cardiovascular and cerebrovascular diseases.: 2026 NVI review casts chronic inflammation as one of four convergent mechanisms disrupting a shared heart–brain neurovascular interface with aging, framing inflammaging as a substrate for cardiovascular–cerebrovascular comorbidity — narrative synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-08-04 — Association of neurofilament light chain, CXCL9, IL-6, and TNFRSF11B with intrinsic capacity in community-dwelling older adults.: 2026 cross-sectional community-dwelling older-adult study: higher blood NfL is independently associated with lower WHO intrinsic capacity and partially mediates the IC associations of CXCL9 and TNFRSF11B, extending inflammaging protein signatures (IL-6, CXCL9, TNFRSF11B) toward a multidomain functional-capacity readout with neuroaxonal injury as a partial mediator. [human-observational] (novelty: 3)
- 2026-08-07 — Cellular senescence in posterior segment neovascular diseases: A proposed feed-forward amplification model.: 2026 posterior-segment neovascular disease review positions retinal SASP as part of a self-reinforcing inflammation–angiogenesis–fibrosis loop in nAMD and PDR, extending the inflammaging concept to ocular neovascular pathology as a rationale for senomorphic/anti-VEGF combination approaches — conceptual synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-08-05 — The Immunometabolic Bridge: Targeting Metainflammation to Prevent the Transition from Obesity to Cardiovascular Disease.: 2026 review reframes adipose-derived ‘metainflammation’ as an immunometabolic bridge from preclinical obesity to cardiovascular disease that only becomes pathogenic in a permissive metabolic milieu, mapping a tiered prevention ladder (lifestyle/statins → GLP-1 receptor agonists → senolytics) onto the inflammaging concept — conceptual synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-08-10 — Youthfulness of marrow Adipoqcells maintained by Cbfβ facilitates stem cell-based bone repair.: 2026 mouse bone-repair study: age-related Cbfβ decline in marrow Adipoq+ cells drives local BMAC SASP that impairs the skeletal stem/progenitor niche, positioning marrow adipocyte-lineage senescence as a tissue-local inflammaging source in aged bone; senolytics phenocopy the Cbfβ-overexpression rescue. [animal-model] (novelty: 3)
- 2026-08-11 — Beyond senescence entry: Individual-cell fates, population outcomes and therapeutic implications in ageing and disease.: 2026 review frames chronic inflammaging as a downstream signature of failed population-level resolution of senescent cells (rather than uniform SASP output), implying senomorphic modulation of persistent populations may matter more than blanket clearance for sustained inflammatory tone — conceptual synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-08-01 — Cardiometabolic Aging Driven by Multi-Organ Crosstalk: Mechanisms and Therapeutic Strategies.: 2026 cardiac-aging crosstalk review frames systemic inflammaging fed by aged adipose SASP, sarcopenic myokine loss, gut dysbiosis, and CKD-derived uremic toxins as a distributed driver of cardiac senescence, with RAAS/SGLT2 inhibitors, senolytics, and gut/microbiota modulation offered as nodal dampeners — narrative synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-08-17 — Ovarian aging and systemic health: Mechanisms and emerging intervention strategies.: 2026 ovarian-aging review nominates the aging ovary as a sex-specific tissue source of SASP feeding systemic inflammaging in women, tying pre-menopausal ovarian senescence and estrogen loss to the broader post-menopausal inflammatory shift — conceptual synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-08-25 — A geroprotective probiotic and its functional metabolite counteract inflammaging to extend healthspan.: 2026 aged-mouse study: Bifidobacterium pseudocatenulatum supplementation and its metabolite 5-AVAB reduced multi-organ inflammatory signatures and extended healthspan in naturally aged mice, with the species depleted in aged Chinese cohorts — a concrete species/metabolite-level anti-inflammaging axis (mouse causal + human observational depletion). [animal-model] (novelty: 4)
- 2026-07-06 — Microbiome and aging: Trajectories of microbiome age across human ecosystems and their systemic effects.: 2026 microbiome-age review argues that convergent dysbiosis across body habitats feeds systemic low-grade inflammation, framing multi-ecosystem microbial aging as an upstream contributor to inflammaging tone — conceptual synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-08-28 — Identifying novel druggable targets and repurposable drugs for premature ovarian insufficiency by integrated multiomics and causal inference analysis.: 2026 POI proteomic MR study includes inflammatory/immunomodulatory candidates (e.g., FSTL3) among seven causal targets for ovarian failure, offering an indirect thread from systemic protein-level inflammation to reproductive aging — target-discovery signal only, no cytokine or SASP measurement. [human-observational] (novelty: 3)
- 2026-09-01 — Solute Carrier Family 1 Member 5 (SLC1A5)-dependent glutamine transport regulates macrophage senescence and efferocytosis during liver regeneration.: 2026 mouse partial-hepatectomy study: loss of macrophage SLC1A5-dependent glutamine transport drives Kupffer-cell senescence and impaired Gas6-mediated efferocytosis, framing defective apoptotic-cell clearance by senescent tissue macrophages as a mechanism sustaining hepatic inflammaging during regeneration. [animal-model] (novelty: 3)
- 2026-08-18 — Spatial niche remodeling of senescent liver-resident immune cells and its role in chronic liver diseases.: 2026 review synthesizes liver-resident immune-cell senescence as a spatially organized (portal–central axis) SASP source driving hepatic inflammaging and steatosis→fibrosis→HCC progression, positioning subset-specific senotherapeutics as candidate liver-inflammaging interventions — conceptual synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-09-06 — Mitochondria-endoplasmic reticulum contact sites (MERCS/MAM): Multi-layered upstream regulators of microglial senescence in Alzheimer’s disease.: 2026 MERCS/MAM–AD review positions contact-site dysfunction as an upstream amplifier of microglial inflammatory signaling in Alzheimer’s disease, adding a mitochondria–ER-interface origin to the growing menu of proposed neuroinflammaging drivers — synthesis with limited direct microglial evidence. [mechanism-plausible] (novelty: 3)
- 2026-09-05 — Longitudinal infection trajectories and biological aging acceleration in adults: a prospective cohort study.: 2026 prospective Chinese cohort links longitudinal trajectories of frequent/severe infections to greater Klemera–Doubal biological-age acceleration and higher all-cause mortality, with severity gradients and polygenic-susceptibility modulation — human observational evidence framing cumulative infection burden (not isolated severe events) as an aging accelerator plausibly acting via inflammaging. [human-observational] (novelty: 3)
- 2026-09-08 — LAPTM5 correlates with RPE senescence and subretinal fibrosis through the LAPTM5-WWP2-OPTN mitophagy cascade and cGAS/STING activation in a D-galactose-induced aging model.: 2026 D-gal RPE study links LAPTM5-mediated mitophagy failure to cGAS–STING-driven local inflammation and subretinal fibrosis, with STING inhibition attenuating the fibro-inflammatory phenotype — an ocular-tissue instance of the mitophagy-failure → DNA-sensing → inflammaging pattern. [animal-model] (novelty: 3)
- 2026-06-26 — Hormonal dimorphism in sarcopenia disease.: 2026 sarcopenia dimorphism review implicates sex-divergent apelin/insulin/oxytocin signaling as upstream modulators of muscle inflammaging tone, suggesting the female post-menopausal inflammatory shift in muscle is partly hormonally patterned rather than uniform — narrative synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-07-01 — Multi-omics profiling reveals systemic rejuvenation of the aged kidney through senolytic therapy.: 2026 aged-mouse kidney multi-omics: chronic D+Q senolytic therapy normalized multi-cell-type inflammatory communication signatures in the renal single-cell atlas, tying senescent-cell clearance to attenuation of tissue-level inflammaging in a naturally aged organ. [animal-model] (novelty: 3)
- 2026-07-01 — A Non-Canonical Role for Hepatocyte MLKL in Promoting Mitochondrial Dysfunction and Senescence in the Aging Liver.: 2025/2026 mouse hepatocyte MLKL study: hepatocyte MLKL promotes paracrine inflammatory signaling in aged liver via mitochondrial-dysfunction-driven senescence rather than classical necroptotic release, offering a non-cell-death molecular route into tissue inflammaging. [animal-model] (novelty: 3)
- 2026-06-24 — Mitochondrial transcription factor A: linking mtDNA maintenance, mitochondrial stress responses, and inflammaging.: 2026 TFAM review frames TFAM imbalance as an upstream source of cytosolic mtDNA release that feeds cGAS–STING-driven inflammaging, positioning TFAM stoichiometry alongside senescence and mtDNA damage as a mechanistic origin of sterile chronic inflammation — narrative synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-07-13 — Sleep-related Alzheimer’s disease vulnerability in aging: A muscle-metabolic perspective.: 2026 narrative review frames sarcopenia, sarcopenic obesity, and insulin resistance as muscle-metabolic states that amplify sleep disruption and thereby lower the threshold for neuroinflammation and impaired amyloid/tau clearance in AD vulnerability — synthesis linking peripheral inflammaging drivers to CNS inflammatory tone via sleep, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-07-01 — High Intrinsic Aerobic Capacity Is Associated With a Distinct Epigenetic and Signaling Profile in the Aged Rat Brain.: 2026 aged-rat study: high intrinsic aerobic capacity rats show distinct cortical inflammation-related signaling in addition to MAPK/AKT-mTOR changes, consistent with intrinsic fitness as a modifier of neuroinflammaging trajectory independent of exercise training. [animal-model] (novelty: 3)
- 2026-06-29 — Mechanistic redundancy and hierarchy of aging mechanisms: implications for strategies to extend healthspan and biomarker integration.: 2026 hierarchy review casts inflammaging as a tertiary systemic manifestation downstream of primary insults, warning that anti-inflammatory monotherapy will not correct upstream damage accumulation and that female sex-hormone loss is an under-recognized primary contributor to post-menopausal inflammatory shift — conceptual synthesis. [expert-opinion] (novelty: 3)
- 2026-07-16 — Prevention of Vascular Aging as a Novel Paradigm for GLP-1 Receptor Agonist-Mediated Cardioprotection.: 2026 narrative review proposes GLP-1RA cardiovascular benefit acts via dampening vascular inflammaging (SASP-associated inflammation, altered intercellular communication) and restoring progenitor-cell flux — conceptual synthesis, no new cytokine or trial data. [expert-opinion] (novelty: 3)
- 2026-07-17 — Constitutive mTORC1 activation in skeletal muscle increases inflammation but is not sufficient to impair glucose tolerance.: 2026 muscle-specific Depdc5-KO mouse study shows constitutive mTORC1 activation in adult skeletal muscle is sufficient to induce an inflammatory/immune transcriptional program locally, offering a tissue-intrinsic nutrient-sensing route into inflammaging that is decoupled from glucose-homeostasis changes. [animal-model] (novelty: 3)
- 2026-07-19 — Rethinking frailty as a disorder of mitochondrial adaptability, from energetic congestion to systemic vulnerability.: 2026 frailty perspective places inflammaging downstream of energetic congestion and impaired mitochondrial adaptability, with redox imbalance and mitochondrial signaling proposed as bridges to systemic low-grade inflammation in sarcopenic-obesity frailty — narrative synthesis, no new cytokine or human data. [mechanism-plausible] (novelty: 3)
- 2026-07-01 — Combined Time-Restricted Feeding and Physical Exercise Attenuate ER Stress and Improve Liver Inflammation and Collagen Deposition in Aged Mice.: 2026 aged-mouse study: TRF + mixed exercise reduced hepatic inflammation and collagen deposition beyond TRF alone, linking combined lifestyle levers to attenuation of liver fibro-inflammatory aging via upstream PERK/ER-stress dampening. [animal-model] (novelty: 3)
- 2026-07-23 — Exercise attenuates atherosclerosis by inhibiting eWAT aging via targeting SIRT1/pyruvate carboxylase pathway.: 2026 HFD mouse study links exercise-induced suppression of epididymal WAT senescence (via SIRT1/PC) to reduced atherosclerosis, consistent with adipose-tissue SASP as a peripheral driver of vascular inflammaging — mechanism inferred from senescence markers and senolytic phenocopy, not direct cytokine causal chain. [animal-model] (novelty: 3)
- 2026-07-14 — TRF2 enriched cytoplasmic chromatin drives cGAS-STAT1-mediated inflammation in senescence.: 2026 preclinical study nominates TRF2-enriched cytoplasmic chromatin → cGAS–STAT1 as a molecular substrate for SASP-driven inflammaging, and shows metformin (already an inflammaging-adjacent candidate) plus JAK–STAT inhibition can suppress it in models. [animal-model] (novelty: 3)
- 2026-08-01 — Epigenetic aging in Alzheimer’s disease: Relation to proteome.: 2026 AD multi-omic study: blood epigenetic age acceleration correlates with CSF proteomic modules enriched for immune/inflammatory pathways and with AT(N) biomarkers, offering an indirect human observational link between systemic epigenetic aging and CNS inflammaging in AD. [human-observational] (novelty: 3)
- 2026-08-10 — Preserving joint healthspan in knee osteoarthritis: a geroscience-guided review of non-surgical therapies and genicular artery embolization.: 2026 KOA review positions joint inflammaging (synovial low-grade inflammation, cytokine-driven cartilage catabolism) as a mechanistic anchor for the ‘joint aging’ phenotype, while cautioning that current pharmacologic and injectable anti-inflammatory therapies modulate symptoms without demonstrated impact on the underlying inflammaging trajectory — synthesis, no new cytokine data. [expert-opinion] (novelty: 3)
- 2026-08-07 — Stress management by benzodiazepines in septic shock and critical illness: mechanistic and clinical evidence supporting alternative sedative strategies.: 2026 review frames post-sepsis and post-intensive-care syndromes as benzodiazepine-amplified chronic inflammation + immunosuppression states, positioning ICU sedation choice as an iatrogenic modulator of inflammaging trajectory in survivors — mechanistic/clinical synthesis, no new cytokine or outcome trial data. [mechanism-plausible] (novelty: 3)
- 2026-08-12 — Youth-associated protein TIMP2 regulates microglial state and function in healthy and aged mice.: 2026 mouse study: TIMP2 deletion elevates microglial activation and extracellular inflammatory stress in aged brain, and TIMP2 supplementation dampens these features — nominates a circulating youth-associated protein as a bidirectional modulator of CNS inflammaging distinct from cytokine-centric peripheral models. [animal-model] (novelty: 3)
- 2026-08-17 — Protein restriction and the hallmarks of aging: A coordinated physiological adaptive response?: 2026 protein-restriction review lists dampened inflammaging among the hallmarks coordinately engaged by PR via nutrient-sensing plus endocrine/neural coordination; framing claim only, no new inflammatory data. [mechanism-plausible] (novelty: 3)
- 2026-08-17 — Microglia activation by derepression of endogenous retroviruses drives inflammation and cellular senescence.: 2026 mouse microglia study: DAXX downregulation with age unleashes retrotransposable elements, driving interferon signaling and inflammatory activation in brain-resident macrophages — proposes an intrinsic chromatin origin for neuroinflammaging distinct from peripheral cytokine drivers. [animal-model] (novelty: 3)
- 2026-09-01 — hTERT Immortalization Stabilizes Human Umbilical Cord MSCs and Maintains Their Small Extracellular Vesicles With Preserved Immunomodulatory Activity and Primordial Follicle-Activating Capacity.: 2026 aged-mouse study: small extracellular vesicles from hTERT-immortalized human umbilical cord MSCs retain young-donor-like immunomodulatory activity and restore primordial follicle activation in aged ovaries, implicating MSC-sEV miR-217-5p/SIRT1 cargo as a modulator of tissue-level inflammaging in a reproductive-aging model. [animal-model] (novelty: 3)
- 2026-08-25 — LMNA R527C pathogenic variant causes an inflammation-driven segmental progeroid syndrome via triggering DNA-sensing pathways.: 2026 LMNA R527C laminopathy study shows cGAS–STING hyperactivation as the inflammation driver in a segmental progeroid syndrome; STING/DNA-sensing blockade suppresses the inflammatory phenotype in patient MSCs and mice, offering a concrete molecular substrate for the inflammaging concept in an accelerated-aging model. [animal-model] (novelty: 3)
- 2026-08-26 — The Reductive Stress Nexus: Integrated Pathways of Metabolic Dysregulation, Senescence and Blood-Brain Barrier Failure in Neurodegenerative Disease and Brain Aging.: 2026 review links reductive stress to inflammasome activation and neuroinflammation via redox-imbalance-driven mitochondrial and senescent-cell signaling at the neurovascular unit; asserted mechanistically, no new cytokine or human data. [mechanism-plausible] (novelty: 3)
- 2026-07-28 — The OmniAge compendium of aging omic biomarkers links mitotic clocks to clonal hematopoiesis and causality.: 2026 OmniAge analysis finds that transcriptomic–epigenetic age-acceleration correlations in sorted immune cells are largely driven by residual cell-type heterogeneity, cautioning that immune-cell clock signals often invoked as inflammaging readouts may partly reflect composition rather than intrinsic inflammatory aging. [human-observational] (novelty: 3)
- 2026-08-17 — Epigenetic Skeletal Muscle Memory: The Impact of Physical Activity on Aging and Post-Injury Regeneration.: Review positions chronic low-grade inflammation as one of the drivers eroding skeletal-muscle epigenetic memory and satellite-cell regenerative capacity with age; mechanistic framing only, no new measurements. [mechanism-plausible] (novelty: 3)
- 2026-08-11 — Senolytic Treatment Triggered by Carotid Occlusion Confers Protection Against Later Acute Ischemic Stroke in Aged Rats.: 2026 aged-rat study: D+Q senolytic treatment following carotid occlusion cut cerebrovascular senescence and downstream infarct expansion, consistent with SASP-driven vascular inflammaging as a modifiable contributor to age-related stroke severity (mechanism inferred, not directly measured as cytokine panel). [animal-model] (novelty: 3)
- 2026-07-31 — Early life sugar rationing and ageing related diseases, biological ageing and mortality.: cross-connection with mtor-nutrient-sensing: Early-life sugar rationing signal spans hallmark-related disease incidence and biological-age clocks, implicating both nutrient-sensing (AMPK/mTOR proteomic shifts) and downstream inflammation-linked aging outcomes. (novelty: 4)
Open questions
Related
Contributing findings
Inflammatory biomarkers in late-life depression: a systematic review and meta-analysis of interleukin-1β, interleukin-6, tumor necrosis factor-α, and C-reactive protein.
15-nov-2026
novelty 3
per-area 3
strengthens
Immunosenescence and vaccine adjuvants in older adults: from immune decline to signal reconstitution strategies.
14-nov-2026
novelty 3
per-area 3
strengthens
Beyond Hematopoiesis: How Immune Are Hematopoietic Stem Cells?
14-nov-2026
novelty 3
per-area 3
strengthens
Vascular Aging and Microcirculation: Physiological Aspects of Vascular Aging in the Elderly Population (VAMP-Aging)
13-nov-2026
novelty 2
per-area 2
mentions
The M1/M2 View of Macrophage Polarization is a Considerable Simplification
13-nov-2026
novelty 2
per-area 2
mentions
Metabolic syndrome and Alzheimer's disease: Mechanistic links and precision prevention (Review).
13-nov-2026
novelty 2
per-area 2
strengthens
Cellular senescence and the hallmarks of ageing: Evaluating evidence for a causal mechanistic role.
13-nov-2026
novelty 3
per-area 3
strengthens
The Gut Microbiome in Aging
13-nov-2026
novelty 2
per-area 2
mentions
Premature immune aging in obesity: a testable framework linking immunosenescence, metaflammation, and multiorgan dysfunction.
12-nov-2026
novelty 2
per-area 2
mentions
Reframing the gut-muscle axis through the lens of functional redundancy: A conceptual framework for chronic sarcopenia, acute muscle wasting, and microbiota-related interventions.
12-nov-2026
novelty 2
per-area 1
mentions
Chronobiology of Aging: Interactions Between Circadian Rhythms, Oxidative Stress, and Inflammation.
12-nov-2026
novelty 3
per-area 3
strengthens
Epigenetic regulation of the complement system in age-related chronic inflammation: mechanisms and therapeutic prospects.
12-nov-2026
novelty 2
per-area 2
strengthens
Granzyme K is a driver of age-related tissue remodeling and functional decline independently of age-associated immune dysfunction.
12-nov-2026
novelty 4
per-area 4
strengthens
The neuro-inflammaging triangle: a self-amplifying circuit of protein pathology, senescence-associated secretory phenotype and innate immunity in neurodegenerative disease.
10-nov-2026
novelty 3
per-area 3
strengthens
Evidence generation for diabetes prevention and treatment through the integration of clinical medicine, nutritional epidemiology, and behavioral science.
10-nov-2026
novelty 2
per-area 2
strengthens
Inflammaging and Poor Sleep Contribute to One Another
09-nov-2026
novelty 2
per-area 2
strengthens
TMAO regulates renal tubular epithelial cell senescence through circVmn2r1.
09-nov-2026
novelty 3
per-area 3
strengthens
n-3 polyunsaturated fatty acids ameliorate obesity with cognitive impairment by promoting adipose browning and remodeling of brain lipid metabolism.
09-nov-2026
novelty 3
per-area 2
strengthens
Cytokines and hematological indices as potential markers of low cardiorespiratory fitness and sarcopenia in hemodialysis patients.
09-nov-2026
novelty 2
per-area 2
strengthens
Divergent Effects of Caloric Restriction and Endurance Training on Adipose Macrophage-Related Gene Expression in Aged Wistar Rats.
05-nov-2026
novelty 2
per-area 2
strengthens
Longitudinal associations between the hallmarks of aging and body composition: a narrative review.
04-nov-2026
novelty 3
per-area 3
strengthens
The AIM2 inflammasome drives age-dependent cardiac dysfunction following ischemia-reperfusion in mice.
01-nov-2026
novelty 3
per-area 3
strengthens
When genomes burn: how DNA damage ignites inflammation and fuels ageing.
01-nov-2026
novelty 2
per-area 2
strengthens
Inflammaging as a Dynamic Process in Ageing: Context, Regulation and Functional Consequences.
01-nov-2026
novelty 3
per-area 3
strengthens
Adult-onset Still's disease and sarcopenia-related traits - muscle mass, strength, and function: A bi-directional Mendelian randomization study.
01-nov-2026
novelty 2
per-area 2
strengthens
Constitutive Activation of Skeletal Muscle mTORC1 Drives Pro-Inflammatory Gene Expression in Skeletal Muscle of Aged Mice.
01-nov-2026
novelty 3
per-area 3
strengthens
Multi-Omics Reveals STAT1 as a Central Regulator of Oxidative Stress-Induced Senescence in the Aging Retina.
01-nov-2026
novelty 3
per-area 3
strengthens
Cardiovascular resilience in centenarians.
26-oct-2026
novelty 3
per-area 3
strengthens
Identification of TAS2R-targeting bioactive compounds against metabolic decline: A novel ex vivo methodology based on enteroendocrine and inflammatory readouts.
26-oct-2026
novelty 3
per-area 2
strengthens
Leptin Neutralization Attenuates Inflammaging in Endothelial and Immune Cell Models.
23-oct-2026
novelty 3
per-area 3
strengthens
Cardiovascular health and longevity: where are we?
22-oct-2026
novelty 2
per-area 2
mentions
Relationship Between Social Isolation, Loneliness, and Systemic Inflammation: A Scoping Review of Biological Signatures and Clinical Outcomes.
21-oct-2026
novelty 3
per-area 3
strengthens
Associations of longitudinal patterns of central obesity and chronic low-grade inflammation with incident frailty in middle-aged and older adults.
21-oct-2026
novelty 3
per-area 3
strengthens
Obesity-induced oxidative stress and cGMP depletion suppress cerebellar α2,3-Na,K-ATPase activity in female mice.
20-oct-2026
novelty 2
per-area 2
strengthens
Resistance Training Improves Respiratory Muscle Strength and Immune Response in Older Adults: A Randomized Clinical Trial.
19-oct-2026
novelty 3
per-area 3
strengthens
Caffeine and Exercise in Obesity-Associated Brain Aging and Neurodegeneration: Mechanistic Insights into AMPK/SIRT1/PGC-1α, BDNF/TrkB, and NLRP3 Inflammasome Signaling.
16-oct-2026
novelty 2
per-area 2
strengthens
Feeling lonelier with reduced social contact in everyday life predicts elevated inflammation.
15-oct-2026
novelty 3
per-area 2
strengthens
Fractional-order dynamical modelling of neurophysiological reaction-diffusion model of adiposity-induced cognitive decline using physics-informed neural networks.
15-oct-2026
novelty 2
per-area 2
strengthens
Chrononutrition in the aging era: Circadian regulation of metabolism, resilience, and healthy longevity.
13-oct-2026
novelty 2
per-area 2
strengthens
The mechanism of dietary intervention in delaying brain aging and neurodegenerative diseases.
13-oct-2026
novelty 2
per-area 2
strengthens
Biological Aging, Adiposity, and Inflammation in Degenerative Spine Disease: Mendelian Randomization and Longitudinal United Kingdom Biobank Analyses.
12-oct-2026
novelty 3
per-area 3
strengthens
When Does Polyendocrine Metabolic Ovarian Syndrome (PMOS) Change Definition? A Lifespan Perspective on Menopause and Metabolic Health.
12-oct-2026
novelty 3
per-area 3
strengthens
Bone marrow adipose tissue in cardiometabolic disease: marrow niche remodeling, inflammatory hematopoiesis, and vascular pathology.
10-oct-2026
novelty 3
per-area 3
strengthens
THE AGING PURINOME: A PURINERGIC FRAMEWORK LINKING THE HALLMARKS OF AGING TO INFLAMMAGING.
10-oct-2026
novelty 3
per-area 3
strengthens
Decoding the immune regulation of ovarian aging: mechanisms and therapeutic strategies.
09-oct-2026
novelty 3
per-area 3
strengthens
Is There a Relationship Between the Gut Microbiome and the Functional Capabilities of Skeletal Muscle? A Narrative Review.
08-oct-2026
novelty 2
per-area 2
mentions
Organoids for modeling cellular senescence and age-related pathology: From experimental reconstruction to mechanistic and translational applications.
08-oct-2026
novelty 2
per-area 1
mentions
Biomarker-Guided, Stage-Specific Senotherapy for Metabolic Dysfunction-Associated Steatotic Liver Disease.
08-oct-2026
novelty 3
per-area 3
strengthens
Gut microbiota alterations associated with dietary inflammation and sarcopenia in humans and aged mice: insights from integrated metabolomic analysis.
07-oct-2026
novelty 3
per-area 3
strengthens
Chronic inflammation and multiple dimensions of aging among women in the Philippines.
07-oct-2026
novelty 3
per-area 3
strengthens